Suppr超能文献

吸烟对静脉溶栓治疗脑卒中后临床结局和再通的影响:多中心队列研究。

Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.

机构信息

From the Department of Neurology, University Hospital Berne, Switzerland (R.K., T.H., U.F., M.A., H.S.).

Stroke Center and Neurology, University Hospital Basel, Switzerland (S.T.E., P.A.L., H.G.).

出版信息

Stroke. 2018 May;49(5):1170-1175. doi: 10.1161/STROKEAHA.117.017976. Epub 2018 Apr 10.

Abstract

BACKGROUND AND PURPOSE

The impact of smoking on prognosis after stroke is controversial. We aimed to assess the relationship between smoking status and stroke outcome after intravenous thrombolysis in a large cohort study by adjusting for potential confounders and incorporating recanalization rates.

METHODS

In a prospective observational multicenter study, we analyzed baseline and outcome data of consecutive patients with acute ischemic stroke treated with intravenous thrombolysis. Using uni- and multivariable modeling, we assessed whether smoking was associated with favorable outcome (modified Rankin Scale score of 0-1) and mortality. In addition, we also measured the occurrence of symptomatic intracranial hemorrhage and recanalization of middle cerebral artery. Patients reporting active cigarette use were classified as smokers.

RESULTS

Of 1865 patients, 19.8% were smokers (n=369). They were younger (mean 63.5 versus 71.3 years), less often women (56% versus 72.1%), and suffered less often from hypertension (61.3% versus 70.1%) and atrial fibrillation (22.7% versus 35.6%) when compared with nonsmokers. Favorable outcome and 3-month mortality were in favor of smokers in unadjusted analyses (45.8% versus 39.5% and 9.3% versus 15.8%, respectively), whereas symptomatic intracranial hemorrhage was comparable in both cohorts. Smoking was not associated with clinical outcome and mortality after adjusting for confounders (odds ratio, 1.20; 95% confidence interval, 0.91-1.61; =0.197 and odds ratio, 1.08; 95% confidence interval, 0.68-1.71; =0.755, respectively). However, smoking still independently predicted recanalization of middle cerebral artery in multivariable analyses (odds ratio, 2.68; 95% confidence interval, 1.11-6.43; =0.028).

CONCLUSIONS

Our study suggests that good outcome in smokers is mainly related to differences in baseline characteristics and not to biological effects of smoking. The higher recanalization rates in smokers, however, call for further studies.

摘要

背景与目的

吸烟对卒中预后的影响仍存在争议。我们旨在通过调整潜在混杂因素并结合再通率,在一项大型队列研究中评估吸烟状况与静脉溶栓后卒中结局之间的关系。

方法

在一项前瞻性观察性多中心研究中,我们分析了连续接受静脉溶栓治疗的急性缺血性卒中患者的基线和结局数据。使用单变量和多变量模型,评估吸烟与良好结局(改良 Rankin 量表评分 0-1)和死亡率之间的关系。此外,我们还测量了症状性颅内出血和大脑中动脉再通的发生情况。报告有吸烟史的患者被归类为吸烟者。

结果

在 1865 例患者中,19.8%为吸烟者(n=369)。与不吸烟者相比,吸烟者年龄更小(平均 63.5 岁比 71.3 岁)、女性比例更低(56%比 72.1%)、高血压(61.3%比 70.1%)和心房颤动(22.7%比 35.6%)的发生率更低。在未校正分析中,吸烟者的良好结局和 3 个月死亡率更高(分别为 45.8%比 39.5%和 9.3%比 15.8%),而两组的症状性颅内出血发生率相当。在校正混杂因素后,吸烟与临床结局和死亡率无关(比值比,1.20;95%置信区间,0.91-1.61;=0.197 和比值比,1.08;95%置信区间,0.68-1.71;=0.755)。然而,在多变量分析中,吸烟仍然独立预测大脑中动脉再通(比值比,2.68;95%置信区间,1.11-6.43;=0.028)。

结论

我们的研究表明,吸烟者的良好结局主要与基线特征的差异有关,而与吸烟的生物学效应无关。然而,吸烟者的再通率较高,需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验